[Long-term results of gentamycin therapy of Menière's disease]

R E Blessing1, W W Schlenter

  • 1Hals-Nasen-Ohrenklinik der Medizinischen Universität zu Lübeck.

Laryngo- Rhino- Otologie
|December 1, 1989
PubMed

Insights

Daily tympanoclysis with gentamicin effectively treated Ménière

Area of Science:

  • Otolaryngology
  • Neurology

Context:

  • Ménière's disease is a chronic inner ear disorder.
  • Current treatments aim to manage vertigo and preserve hearing.

Purpose:

  • To evaluate the efficacy and safety of daily tympanoclysis with gentamicin for Ménière's disease.

Summary:

  • 82 Ménière's disease patients received daily gentamicin via tympanoclysis.
  • 89% of patients achieved vertigo elimination.
  • Hearing outcomes varied, with better results in low-frequency hearing loss cases.

Impact:

  • Gentamicin tympanoclysis offers a simple, safe, and effective treatment option.
  • This method can significantly improve quality of life for patients with disabling Ménière's disease.